Patents Assigned to SHANGHAI YUNYING BIOPHARMACEUTICAL TECHNOLOGY CO., LTD.
  • Oncolytic virus vector and application thereof
    Patent number: 11987802
    Abstract: The embodiments of the present disclosure may provide an oncolytic virus vector and an application thereof. The oncolytic virus vector may comprise a recombinant nucleic acid. The recombinant nucleic acid may include: (i) a first nucleic acid fragment encoding a soluble PD-1 molecule; (ii) a second nucleic acid fragment encoding a CD86 molecule; and (iii) a third nucleic acid fragment encoding an antibody to a CD3 molecule.
    Type: Grant
    Filed: July 11, 2023
    Date of Patent: May 21, 2024
    Assignee: SHANGHAI YUNYING BIOPHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventors: Ziying Gong, Daoyun Zhang, Yonghua Sun, Yi Wang, Nan Shi, Jun Zhu, Miao Ding
  • ONCOLYTIC VIRUS VECTOR AND APPLICATION THEREOF
    Publication number: 20240002884
    Abstract: The embodiments of the present disclosure may provide an oncolytic virus vector and an application thereof. The oncolytic virus vector may comprise a recombinant nucleic acid. The recombinant nucleic acid may include: (i) a first nucleic acid fragment encoding a soluble PD-1 molecule; (ii) a second nucleic acid fragment encoding a CD86 molecule; and (iii) a third nucleic acid fragment encoding an antibody to a CD3 molecule.
    Type: Application
    Filed: July 11, 2023
    Publication date: January 4, 2024
    Applicant: SHANGHAI YUNYING BIOPHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventors: Ziying GONG, Daoyun ZHANG, Yonghua SUN, Yi WANG, Nan SHI, Jun ZHU, Miao DING